SARAH BALITSARIS: Open Payments
NPI 1578996930 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$272 in 11 payments from 9 companies in 2025. Trend: 2023 $972 · 2024 $824 · 2025 $272
Food & beverage: $272
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| CSL Behring | 1 | $32 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| Optinose US, Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $25 |
| BioCryst US Sales Co., LLC | 1 | $24 |
| Amgen Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
Products named: DUPIXENT, Andembry, NEFFY, Xhance, Xolair, ORLADEYO, NUCALA, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
